CCA
LLY icon

Coign Capital Advisors’s Eli Lilly LLY Stock Holding History

Coign Capital Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1M Buy
836
+4
+0.5% +$4.09K 0.45% 35
2026
Q1 		$765K Sell
832
-34
-4% -$34.5K 0.4% 49
2025
Q4 		$931K Buy
866
+11
+1% +$10.5K 0.49% 32
2025
Q3 		$652K Buy
855
+66
+8% +$49.1K 0.36% 60
2025
Q2 		$615K Buy
789
+18
+2% +$14K 0.42% 54
2025
Q1 		$637K Sell
771
-6
-0.8% -$4.99K 0.49% 44
2024
Q4 		$600K Buy
+777
New +$643K 0.55% 47

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Coign Capital Advisors's LLY Position: Q2 2026 in Review

Coign Capital Advisors increased its Eli Lilly (LLY) stake by 0.48% in Q2 2026, buying an estimated $4.09K and bringing the position to 836 shares worth $1M. The position accounts for 0.45% of the portfolio, ranked #35.

Coign Capital Advisors first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,631 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Coign Capital Advisors held 836 shares of Eli Lilly worth $1M as of Q2 2026.
  • Coign Capital Advisors bought 4 Eli Lilly shares in Q2 2026, an estimated $4.09K.
  • Eli Lilly made up 0.45% of Coign Capital Advisors's portfolio in Q2 2026, its #35 holding.
  • Coign Capital Advisors first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,631 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Coign Capital Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.